20 October 2015

NICE, Level 1, City Tower, Piccadilly Plaza, Manchester

The meeting will start promptly at 10:00 and is expected to finish at approximately 17:00

Please note that this agenda is subject to change prior to the meeting.

Final Agenda

1. Welcome and introduction to format of meeting - Part 1 only (open session)

2. Apologies - Part 1 only (open session)

3. Any other business - Part 1 only (open session)

4. Appraisal of Evolocumab for treating primary hyperlipidaemia and mixed dyslipidaemia [ID765]

4.1. Declarations of interest - Part 1 only (open session)

4.2. Introduction by the Chair, Professor Andrew Stevens - Part 1 only (open session)

4.3. Presentation by the Lead team Dr Anna o'Neill, Professor Rachel Elliott and Dr Judith Wardle Part 1 AND Part 2 (open and closed session)

4.4. Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

5. Appraisal of Ramucirumab for treating advanced gastric cancer or gastro-oesophageal junction adenocarcinoma after chemotherapy [ID741]

5.1 Declarations of interest - Part 1 only (open session)

5.2 Introduction by the Chair, Professor Andrew Stevens - Part 1 only (open session)

5.3 Presentation by the Chair, Professor Andrew Stevens Part 1 AND Part 2 (open and closed session)

5.4 Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

6. Appraisal of Panobinostat for treating multiple myeloma in people who have received at least one prior therapy [ID663]

6.1 Declarations of interest - Part 1 only (open session)

6.2 Introduction by the Chair, Professor Andrew Stevens - Part 1 only (open session)

6.3 Presentation by the Chair, Professor Andrew Stevens - Part 1 AND Part 2 (open and closed session)

6.4 Agreement on the content of the Appraisal Consultation Document (ACD) or Final Appraisal Determination (FAD) - Part 2 only (closed session)

 Date, time and venue of next meeting

Wednesday 18 November 2015, 10:00am, NICE, Level 1, City Tower, Piccadilly Plaza, Manchester, M1 4BT.

Please note all timings are approximate.

To print this agenda, please right click and select ‘Print’ from the menu

To register

You will receive an automated email response when you submit the registration form. If you do not receive this automated response your registration request has not been received, and you will need to complete and submit the registration form again.

The closing date for registration is Tuesday 06 October 2015. Please note that it may not be possible to accept late registration requests.

Should you have queries regarding attending this meeting, please contact the Meetings in Public Coordinator Sandra.robinson@nice.org.uk

 

Please note that registrants wishing to conduct a research study on the committee meeting and/or NICE processes will require prior permission and should contact NICE Enquiry Handling by email nice@nice.org.uk   

Further information about conducting research is also available in our Common Questions and Answers about meetings in public document.

 

Registration period: 22 September 2015 to 06 October 2015
Registration is closed.